Eliza Dushku Headlines Joss Whedon's New Dollhouse Think.

Joss Whedon, founder of hit shows Buffy the Vampire Slayer and Angel, as well as the unfortunately cancelled Firefly, is on the point of for video again. His untrodden show, Dollhouse, will disclose on Fox and lead Eliza Dushku. By | Published 4/7/2008 | While some disintegrated standbys will soon be returning, midseason also promises to create some fascinating altered shows to the TV viewers.

From darkness soaps to kitschy comedy, TV networks are scrambling to occupy viewing schedules. By | Published 12/23/2008 | Mid-season is here for the 2008-2009 tube season, and it couldn't come rakishly enough. I think about it's equitably unhurt to remark that the redone TV shows that premiered this quondam be captured didn't have too many hits out of the ballpark. By | Published 12/22/2008 | It's almost set for some unripe shows… here's what you should stopping out (or not).

By | Published 8/13/2008 | Joss Whedon, originator of hit goggle-box show "Buffy The Vampire Slayer," has stepped down from his duty at the tiller of the powerfully anticipated "Wonder Woman" mark film. He cited artistic differences with studio and assembly society executives.

Read the very informative post: click there

Merck To Purchase Insmed News.

WHITEHOUSE STATION, N.J. (AP) -- Merck & Co. said Thursday it will accept a slate of biotech dull candidates and a manufacturing efficiency from Insmed Inc. for $130 million.

Insmed agreed to push its main of "biosimilars," or "follow-on biologic drugs" -- drugs that are attempted copies of biotech drugs, which are made using living cells. In the deal, Merck gains products including INS-19 and INS-20. The drugs are designed to arrest infections in cancer patients who are receiving chemotherapy. Late-stage trials of INS-19 are being planned, and INS-20 is in early-stage testing.

Merck will be advantageous Insmed $10 million upfront for the drugs, and will approve the break of its pay when the deal closes. It will not be in debt to any milestone or royal house payments. The manufacturing assign is a 50,000 square-foot expertness in Boulder, Colo., for the making and review of biologic drugs. The drugs will be managed by Merck\'s imaginative BioVentures business. Richmond, Va.-based Insmed maintains ownership of its protein-based painkiller candidates, including two cancer treatments in antique development, and a agglomeration of candidates based on its deaden Iplex.

Iplex received Food and Drug Administration blessing in 2005 for use in children with lump ruin due to embryonic IGF-I deficiency, or insulin-like enlargement financier deficiency.

With all due respect to post: click

Phoenix. Joaquin Phoenix's Bizarre Letterman Appearance: (VIDEO) Know.

Joaquin Phoenix made a unconventional air on Wednesday night's Letterman to kick upstairs his fog "Two Lovers," during what may be his persist take in as an actor. Phoenix has insisted he is unsociable from haze to focus on his hip-hop career. Phoenix was unresponsive for on the part of of the interview, while giving one conference answers for other questions. As seen in the compilation video below, Phoenix has no intuit of humor about Letterman's teasing over his monosyllabic non-answers. He has an uncomfortable disagreement with Paul Shaffer, gets annoyed at the audience and won't even set up the section from his moving picture "Two Lovers.

" That's before he takes the gum out of his empty and sticks it to Letterman's desk. Letterman ends the interrogate with, "Joaquin, I'm stark you couldn't be here tonight." It must be seen to be appreciated.

I feel reverence to link: link